Entera Bio Ltd. (ENTX) , a clinical-stage company, announced that it has entered into a securities purchase agreement for a private placement led by funds affiliated with BVF Partners L.P under which the company agreed to issue and sell an aggregate of 7.83 million units at a purchase price of $1.2775 per unit.
Each unit consists of one ordinary share of Entera and one five-year warrant to purchase 1.5 ordinary shares at an exercise price of $1.24 per share, based on the closing price on March 31, 2026. The private placement was expected to close on or about April 2, 2026.
The gross proceeds to the company from the private placement were expected to be approximately $10.0 million. If all warrants issued in the private placement are exercised, the company could receive additional proceeds of approximately $14.5 million, bringing total potential proceeds to approximately $24.5 million.
The company intends to use the net proceeds to support activities related to the initiation of the phase 3 registrational study of EB613 in postmenopausal women with osteoporosis and for general working capital and corporate purposes.
The company's most advanced product candidate, EB613, or oral PTH(1-34), is being developed as the first once-daily oral osteoanabolic (bone-building) tablet for osteoporosis and has met the key goals in the dose-ranging Phase 2 study.
ENTX has traded between $0.91 and $3.22 in the last year. The stock closed Thursday's trade (April 2, 2026) at $1.26, up 10.53%.
In the premarket, ENTX is down 4.76% at $1.20.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.